cycloheximide has been researched along with etoposide in 84 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (2.38) | 18.7374 |
| 1990's | 39 (46.43) | 18.2507 |
| 2000's | 36 (42.86) | 29.6817 |
| 2010's | 7 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrows, LR; Ireland, CM; Kokoshka, JM | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Chinnababu, B; Loka Reddy, V; Prakasham, RS; Purushotham Reddy, S; Rao, JV; Sankara Rao, P; Sudheer Kumar, B; Suresh Babu, K | 1 |
| Constantinou, A; Grdina, D; Huberman, E; Kiguchi, K | 1 |
| Beardmore, C; D'Arpa, P; Liu, LF | 1 |
| Kaufmann, SH | 1 |
| Suciu, D | 1 |
| Leblanc, J; Sikorska, M; Smith, C; Walker, PR; Whitfield, JF; Youdale, T | 1 |
| Shionoya, S | 1 |
| Chow, KC; Ross, WE | 1 |
| Chow, KC; King, CK; Ross, WE | 1 |
| Ciriolo, MR; Coppola, S; Ghibelli, L; Lafavia, E; Maresca, V; Rotilio, G | 1 |
| Kato, M; Takada, S; Takayama, S | 1 |
| Aarbakke, J; Endresen, PC; Prytz, PS | 1 |
| Cooper, CS; Horwich, A; Huddart, RA; Robertson, D; Titley, J; Williams, GT | 1 |
| Elvin, P; Hickman, JA; Wood, AC | 1 |
| Farber, JL; Mizumoto, K; Rothman, RJ | 1 |
| Azuma, Y; Kizaki, H; Onishi, Y | 1 |
| Furukawa, S; Hayashi, K; Hayashi, Y; Kashiwagi, K; Kawashima, T; Nakajima, M; Ohta, J | 1 |
| Bennett, MR; Evan, GI; Fanidi, A; Harrington, EA | 1 |
| Goodhead, DT; Greaves, M; Griffiths, SD; Korsmeyer, SJ; Krajewski, S; Marsden, SJ; Reed, JC; Wright, EG | 1 |
| Cohen, GM; Dinsdale, D; Ormerod, MG; Snowden, RT; Sun, XM | 1 |
| Fulka, J; Moor, RM | 1 |
| Bertoglio, J; Bréard, J; Issaad, C; Léglise, MC; Pallardy, M; Roger, R; Turhan, AG | 1 |
| Daxenbichler, G; Lang, T; Marth, C; Müller-Holzner, E; Widschwendter, M | 1 |
| Russev, G; Tsvetkov, L | 1 |
| Pommier, Y; Shao, RG; Shimizu, T | 1 |
| Kataoka, S; Naito, M; Noguchi, K; Tsuruo, T; Yonehara, S | 1 |
| Piette, J; Piret, B | 1 |
| Elsheikh, AS; Hishinuma, M; Kanagawa, H; Takahashi, Y | 1 |
| Akiyama, Y; Furusho, K; Kataoka, A; Koishi, S; Kubota, M; Lin, YW; Sawada, M; Usami, I; Watanabe, Ki | 1 |
| Dragunow, M; MacGibbon, G; Saura, J | 1 |
| Bacon, R; Jobson, T; Kitamura, M; Mooney, A; Savill, J | 1 |
| Hanaoka, F; Okumura, K; Tanaka, A; Yamauchi, Y | 1 |
| Carabillò, M; Giuliano, M; Lauricella, M; Tesoriere, G; Vassallo, E; Vento, R | 1 |
| Athias, A; Bessede, G; Gambert, P; Gueldry, S; Lemaire, S; Lizard, G; Miguet, C; Monier, S; Solary, E; Sordet, O | 1 |
| El-Deiry, WS; Meng, RD; Phillips, P | 1 |
| Bushell, M; Clemens, MJ; Morley, SJ | 1 |
| Golub, EI; Haaf, T; Raderschall, E | 1 |
| Gollahon, KA; Kim, C; Potter, A; Rabinovitch, PS | 1 |
| Engels, IH; Los, M; Rossmann, E; Schulze-Osthoff, K; Wesselborg, S | 1 |
| Bettaieb, A; Bruey, JM; Droin, N; Eymin, B; Garrido, C; Ivarsson, M; Solary, E; Sordet, O | 1 |
| Cohen, GM; Dinsdale, D; Zhuang, J | 1 |
| Koistinen, P; Mäntymaa, P; Säily, M; Savolainen, E; Siitonen, T | 1 |
| Cotter, TG; Knox, KA; McGahon, AJ; McKenna, SL; O'Gorman, DM | 1 |
| Keogh, SA; Martin, SJ; Slee, EA | 1 |
| Frost, V; Sinclair, AJ | 1 |
| Bushell, M; Clemens, MJ; Flotow, H; Lloyd, RE; Marissen, WE; Morley, SJ; Poncet, D | 1 |
| Brady, HP; Coffey, RN; Fitzpatrick, JM; Gibbons, NB; Watson, RW | 1 |
| Kubelka, M; Moor, RM | 1 |
| Baireddy, V; Strayer, DS; White, MK | 1 |
| Cantoni, C; Daga, A; Lunardi, C; Millo, R; Oliveri, M; Puccetti, A | 1 |
| d'Adda Di Fagagna, F; Freire, R; Hickson, ID; Jackson, SP; Pedrazzi, G; Stagljar, I; Wu, L | 1 |
| Burnside, J; Cheng, G; Kurosaki, T; Kwan, R | 1 |
| Heldebrant, MP; Kaufmann, SH; Meng, XW | 1 |
| Budd, RC; Ito, M; Kataoka, T; Nagai, K; Tschopp, J | 1 |
| Farber, JL; Karpinich, NO; Rothman, RJ; Russo, MA; Tafani, M | 1 |
| Dong, YB; Elliott, MJ; McMasters, KM; Yang, HL | 1 |
| Bach, FH; Berberat, PO; Brouard, S; Günther, L; Haga, M; Smith, RN; Soares, MP; Tobiasch, E | 1 |
| Hatayama, T; Ishihara, K; Saito, Y; Yamagishi, N | 1 |
| Cai, MM; Chen, C; Chen, S; Gu, JX; Hu, Y; Yan, J; Zhang, S; Zhang, SW; Zhu, XY | 1 |
| Ball, KL; Dornan, D; Kelleher, M; Pamment, J; Ramsay, E | 1 |
| Majerus, PW; Mochizuki, Y; Sun, Y | 1 |
| Rikiishi, H; Sato, K; Shinohara, F; Suzuki, M; Takada, H; Taniguchi, T | 1 |
| Moreau, M; Novak, S; Pothier, F; Saint-Cyr, A; Savard, C; Sirard, MA | 1 |
| Berger, SA; Zhang, Y | 1 |
| Fulka, H; Fulka, J; Loi, P; Nagai, T; Ptak, G | 1 |
| Bor, MV; Nexø, E; Sørensen, BS; Tørring, N | 1 |
| Chen, DF; Liu, MJ; Wang, Z; Wu, RC | 1 |
| Chan, BC; Chan, JY; Ching, AK; Chow, SK; Chui, YL; Ho, TC; Ip, WK; Lam, CW; Lee, KK; Li, Q; Lim, PL; Wong, CK | 1 |
| Choi, HY; Jeon, YK; Kim, CW; Kim, H; Kim, JE; Kim, YA; Kim, YN; Park, SO; Park, SS | 1 |
| de Léséleuc, L; Denis, F | 1 |
| Bennett, LN; Clarke, CA; Clarke, PR | 1 |
| Bell, CW; Jiang, W; Pisetsky, DS; Reich, CF | 1 |
| Bai, J; Cederbaum, AI | 1 |
| Mannherz, HG; Mazur, A; Meller, K; Theiss, C | 1 |
| Abayasiriwardana, KS; Barbone, D; Broaddus, VC; Dansen, TB; Evan, GI; Hunt, AE; Kim, KU; Lee, KK; Vivo, C | 1 |
| Aplin, AE; Hu, R | 1 |
| Kopacek, J; Krizanova, O; Labudova, M; Lencesova, L; Ondrias, K; Pastorekova, S; Sirova, M | 1 |
| Maquat, LE; Popp, MW | 1 |
| Barteneva, NS; Vorobjev, IA | 1 |
2 review(s) available for cycloheximide and etoposide
| Article | Year |
|---|---|
Nucleus transfer in mammals: noninvasive approaches for the preparation of cytoplasts.
Topics: Animals; Animals, Domestic; Centrifugation, Density Gradient; Cloning, Organism; Cycloheximide; Cytological Techniques; Demecolcine; Etoposide; Ionomycin; Mammals; Maturation-Promoting Factor; Metaphase; Mice; Micromanipulation; Microscopy, Fluorescence; Microscopy, Polarization; Nocodazole; Nuclear Transfer Techniques; Oocytes; Spindle Apparatus; Sucrose | 2004 |
Multi-parametric imaging of cell heterogeneity in apoptosis analysis.
Topics: Algorithms; Apoptosis; Carbocyanines; Caspase 3; Caspase 7; Cycloheximide; Etoposide; Flow Cytometry; Fluorescent Dyes; Gene Expression Regulation; HeLa Cells; Humans; Image Cytometry; Jurkat Cells; Organometallic Compounds; Software; Staining and Labeling | 2017 |
82 other study(ies) available for cycloheximide and etoposide
| Article | Year |
|---|---|
Cell-based screen for identification of inhibitors of tubulin polymerization.
Topics: Animals; Brain Neoplasms; Bucladesine; Cell Differentiation; Drug Screening Assays, Antitumor; Formazans; Glioma; Rats; Tubulin; Tumor Cells, Cultured | 1996 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Isolation, semi-synthesis and bio-evaluation of spatane derivatives from the brown algae Stoechospermum marginatum.
Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Microbial Sensitivity Tests; Phaeophyceae; Structure-Activity Relationship | 2015 |
The effect of topoisomerase inhibitors on the expression of differentiation markers and cell cycle progression in human K-562 leukemia cells.
Topics: Amsacrine; Aphidicolin; Cell Cycle; Cell Differentiation; Cycloheximide; Deoxyadenosines; Dose-Response Relationship, Drug; Etoposide; G2 Phase; Hemoglobins; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanins; Mitosis; Novobiocin; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1992 |
Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.
Topics: Amsacrine; Animals; Antibiotics, Antineoplastic; Aphidicolin; Camptothecin; Cell Survival; Cricetinae; Cricetulus; Cycloheximide; Deoxyadenosines; Dichlororibofuranosylbenzimidazole; Diterpenes; DNA; Etoposide; Mutagens; Nucleic Acids; RNA; Time Factors; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1990 |
Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.
Topics: Amsacrine; Aphidicolin; Blotting, Western; Camptothecin; Colony-Forming Units Assay; Cycloheximide; Daunorubicin; Deoxyadenosines; Dichlororibofuranosylbenzimidazole; Diterpenes; DNA Polymerase II; DNA Replication; Drug Synergism; Etoposide; Female; Humans; Leukemia, Promyelocytic, Acute; Mutagens; RNA; Topoisomerase II Inhibitors; Topotecan; Tumor Cells, Cultured | 1991 |
Reproductive death of Chinese hamster V79 cells after exposure to chemical inhibitors of DNA synthesis.
Topics: 4-Nitroquinoline-1-oxide; Amsacrine; Animals; Benzamides; Bisbenzimidazole; Cell Division; Cell Line; Cisplatin; Cricetinae; Cricetulus; Cycloheximide; DNA Replication; Etoposide; Gene Expression Regulation; In Vitro Techniques; Kinetics; Methylnitronitrosoguanidine; Puromycin; Teniposide; Transcription, Genetic; Uracil | 1991 |
Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes.
Topics: Amsacrine; Animals; Cycloheximide; Dactinomycin; Dexamethasone; DNA; Electrophoresis; Etoposide; Flow Cytometry; Lymphocytes; Mitosis; Rats; Rats, Inbred Strains; Teniposide; Thymus Gland; Time Factors; Topoisomerase II Inhibitors | 1991 |
Etoposide inhibition of methylaminoisobutyric acid transport and its recovery in K562 cells.
Topics: Aminoisobutyric Acids; Biological Transport; Cell Division; Cycloheximide; Depression, Chemical; Etoposide; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Sodium; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1991 |
Topoisomerase-specific drug sensitivity in relation to cell cycle progression.
Topics: Animals; Aphidicolin; Cell Cycle; Cell Line; Cell Survival; Cycloheximide; Diterpenes; DNA Damage; DNA Topoisomerases, Type II; Drug Administration Schedule; Etoposide; Interphase; Mice; Mitosis | 1987 |
Abrogation of etoposide-mediated cytotoxicity by cycloheximide.
Topics: Animals; Cell Cycle; Cells, Cultured; Cycloheximide; DNA; DNA Damage; Etoposide; Humans; Mice; Protein Biosynthesis | 1988 |
Non-oxidative loss of glutathione in apoptosis via GSH extrusion.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Buthionine Sulfoximine; Cell Line; Cycloheximide; Etoposide; Glutathione; Humans; Hydrogen Peroxide; Kinetics; L-Lactate Dehydrogenase; Methionine Sulfoximine; Oxidation-Reduction; Oxidative Stress; Puromycin | 1995 |
Comparison of lesions induced by intra-articular injections of quinolones and compounds damaging cartilage components in rat femoral condyles.
Topics: Administration, Oral; Animals; Bleomycin; Camptothecin; Cartilage, Articular; Chondroitin Lyases; Ciprofloxacin; Collagenases; Cycloheximide; Ethylmaleimide; Etoposide; Fluorescent Dyes; Hydroxyurea; Injections, Intra-Articular; Iodoacetates; Iodoacetic Acid; Irinotecan; Levofloxacin; Male; Ofloxacin; Papain; Rats; Rats, Sprague-Dawley; Rhodamines; Topoisomerase I Inhibitors | 1994 |
A new flow cytometric method for discrimination of apoptotic cells and detection of their cell cycle specificity through staining of F-actin and DNA.
Topics: Actins; Apoptosis; Cell Cycle; Cycloheximide; Dactinomycin; DNA, Neoplasm; Etoposide; Evaluation Studies as Topic; Flow Cytometry; Humans; Leukemia; Microscopy, Confocal; Phalloidine; Propidium; Staining and Labeling; Tumor Cells, Cultured | 1995 |
Programmed cell death in response to chemotherapeutic agents in human germ cell tumour lines.
Topics: Apoptosis; Cisplatin; Cycloheximide; Electrophoresis, Agar Gel; Etoposide; Flow Cytometry; Germinoma; Humans; Ionomycin; Male; Microscopy, Electron; Microscopy, Fluorescence; Testicular Neoplasms; Tumor Cells, Cultured | 1995 |
Induction of apoptosis by anti-cancer drugs with disparate modes of action: kinetics of cell death and changes in c-myc expression.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Death; Cycloheximide; Dexamethasone; Etoposide; Formamides; Gene Expression; Genes, myc; Humans; Leukemia-Lymphoma, Adult T-Cell; Tumor Cells, Cultured | 1995 |
Programmed cell death (apoptosis) of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkylating Agents; Animals; Apoptosis; Cell Division; Cycloheximide; DNA; Etoposide; Isoquinolines; L Cells; Methylnitrosourea; Mice; Piperazines; Protein Biosynthesis; Protein Kinase C; Protein Synthesis Inhibitors; Topoisomerase II Inhibitors | 1994 |
bis(2,6-dioxopiperaxine) derivatives, topoisomerase II inhibitors which do not form a DNA cleavable complex, induce thymocyte apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cells, Cultured; Cycloheximide; Dactinomycin; DNA Damage; Dose-Response Relationship, Drug; Etoposide; Gene Expression Regulation; Male; Mice; Mice, Inbred BALB C; Nucleic Acid Conformation; Piperazines; Razoxane; Thymus Gland; Topoisomerase I Inhibitors | 1994 |
Etoposide induces programmed death in neurons cultured from the fetal rat central nervous system.
Topics: Animals; Apoptosis; Cells, Cultured; Cerebral Cortex; Cycloheximide; Dactinomycin; DNA; DNA Damage; Dose-Response Relationship, Drug; Etoposide; Kinetics; Neurons; Rats; Rats, Wistar; Time Factors | 1994 |
c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines.
Topics: Animals; Apoptosis; Cells, Cultured; Culture Media, Serum-Free; Cycloheximide; Cytokines; Estradiol; Etoposide; Fibroblasts; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Mesoderm; Mice; Platelet-Derived Growth Factor; Protein Biosynthesis; Proto-Oncogene Proteins c-myc; Rats; Signal Transduction; Somatomedins; Thymidine | 1994 |
Interleukin 7-dependent B lymphocyte precursor cells are ultrasensitive to apoptosis.
Topics: Alpha Particles; Animals; Apoptosis; B-Lymphocytes; Bone Marrow Cells; Cells, Cultured; Cisplatin; Clone Cells; Colony-Forming Units Assay; Cycloheximide; Dexamethasone; DNA Damage; Etoposide; Gene Transfer Techniques; Hematopoietic Stem Cells; Humans; Interleukin-7; Kinetics; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Plutonium; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Spleen; Time Factors; X-Rays | 1994 |
Changes in nuclear chromatin precede internucleosomal DNA cleavage in the induction of apoptosis by etoposide.
Topics: Apoptosis; Cell Nucleus; Cells, Cultured; Chromatin; Cycloheximide; Dactinomycin; DNA; Endonucleases; Etoposide; Flow Cytometry; Nucleosomes; Zinc | 1994 |
Noninvasive chemical enucleation of mouse oocytes.
Topics: Animals; Cell Nucleus; Cycloheximide; Etoposide; Female; In Vitro Techniques; Maturation-Promoting Factor; Meiosis; Mesothelin; Mice; Nuclear Transfer Techniques; Oocytes | 1993 |
BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine-activated killer cells.
Topics: Apoptosis; Camptothecin; Cycloheximide; Cytotoxicity, Immunologic; Dactinomycin; DNA Damage; DNA, Neoplasm; Etoposide; Fusion Proteins, bcr-abl; Hematopoietic Stem Cells; Humans; Hydrogen Peroxide; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Puromycin; Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1996 |
Effects of Taxol on choriocarcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Choriocarcinoma; Chorionic Gonadotropin; Cycloheximide; Etoposide; Female; Humans; Methotrexate; Paclitaxel; Pregnancy; Tumor Cells, Cultured; Uterine Neoplasms | 1995 |
Decreased rates of replicon initiation in mammalian cells.
Topics: Alkaloids; Animals; Antineoplastic Agents; Benzamides; Cisplatin; Cycloheximide; DNA Replication; DNA, Neoplasm; Down-Regulation; Etoposide; Friend murine leukemia virus; Kinetics; Leukemia, Erythroblastic, Acute; Mice; Replicon; Signal Transduction; Staurosporine; Tumor Cells, Cultured | 1996 |
Brefeldin A is a potent inducer of apoptosis in human cancer cells independently of p53.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; Brefeldin A; Camptothecin; Cell-Free System; Cyclin B; Cyclin B1; Cyclins; Cycloheximide; Cyclopentanes; DNA Fragmentation; DNA, Neoplasm; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; HL-60 Cells; HT29 Cells; Humans; Mutation; Protein Synthesis Inhibitors; Staurosporine; Time Factors; Tumor Suppressor Protein p53 | 1996 |
A recessive mutant of the U937 cell line acquired resistance to anti-Fas and anti-p55 tumor necrosis factor receptor antibody-induced apoptosis.
Topics: Antibodies; Apoptosis; bcl-2-Associated X Protein; Cell Line; Cycloheximide; DNA; Etoposide; fas Receptor; Genes, Recessive; Humans; Hybrid Cells; Monocytes; Mutation; Phenotype; Protein Synthesis Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Receptors, Tumor Necrosis Factor; Signal Transduction; Tumor Necrosis Factor-alpha | 1995 |
Topoisomerase poisons activate the transcription factor NF-kappaB in ACH-2 and CEM cells.
Topics: Antioxidants; Camptothecin; Cell Line; Cycloheximide; Dactinomycin; Daunorubicin; DNA; DNA Damage; DNA Topoisomerases, Type I; Etoposide; HIV-1; NF-kappa B; Nucleic Acid Synthesis Inhibitors; Poly(ADP-ribose) Polymerase Inhibitors; Topoisomerase I Inhibitors; Transcriptional Activation; Virus Activation | 1996 |
Developmental ability of mouse late 2-cell stage blastomeres fused to chemically enucleated oocytes in vitro.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blastomeres; Cell Fusion; Cell Nucleus; Cells, Cultured; Cycloheximide; Dose-Response Relationship, Drug; Drug Combinations; Embryonic and Fetal Development; Etoposide; Female; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred ICR; Oocytes; Protein Synthesis Inhibitors | 1997 |
Apoptosis-resistant phenotype selected by alternating exposure to camptothecin and etoposide.
Topics: Antineoplastic Agents; Apoptosis; Arabinofuranosylcytosine Triphosphate; ATP Binding Cassette Transporter, Subfamily B, Member 1; bcl-X Protein; Calcimycin; Camptothecin; Clone Cells; Cycloheximide; Cytarabine; DNA Fragmentation; Drug Resistance, Neoplasm; Etoposide; HL-60 Cells; Humans; Hydroxyurea; Kinetics; Nucleosomes; Phenotype; Proto-Oncogene Proteins c-bcl-2; Ultraviolet Rays | 1997 |
Etoposide-induced PC12 cell death: apoptotic morphology without oligonucleosomal DNA fragmentation or dependency upon de novo protein synthesis.
Topics: Analysis of Variance; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cycloheximide; Dactinomycin; DNA Fragmentation; Etoposide; Immunohistochemistry; Nerve Growth Factors; Nucleosomes; PC12 Cells; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats | 1997 |
Cytokines promote glomerular mesangial cell survival in vitro by stimulus-dependent inhibition of apoptosis.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Cell Line; Cell Survival; Cells, Cultured; Culture Media, Serum-Free; Cycloheximide; Cytokines; Etoposide; fas Receptor; Fibroblast Growth Factor 2; Glomerular Mesangium; Humans; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Kidney Cortex; Paracrine Communication; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats | 1997 |
A mutant strain of mouse FM3A cells defective in apoptotic DNA fragmentation.
Topics: Animals; Apoptosis; Cell Line; Cycloheximide; DNA Damage; DNA Fragmentation; Etoposide; Flow Cytometry; Kinetics; Mice; Phosphatidylserines; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53; Ultraviolet Rays; X-Rays | 1998 |
Induction of apoptosis in human retinoblastoma cells by topoisomerase inhibitors.
Topics: Amsacrine; Apoptosis; bcl-2-Associated X Protein; Camptothecin; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cycloheximide; Dactinomycin; DNA Damage; DNA Topoisomerases, Type I; DNA, Neoplasm; Enzyme Inhibitors; Etoposide; Humans; Insulin-Like Growth Factor Binding Protein 3; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Retinal Neoplasms; Retinoblastoma; Topoisomerase I Inhibitors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |
Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production.
Topics: Acetylcysteine; Antioxidants; Apoptosis; Caspases; Cycloheximide; Cytochrome c Group; DNA Fragmentation; Enzyme Activation; Enzyme Precursors; Etoposide; Fatty Acids, Unsaturated; Free Radicals; Glutathione; Humans; Ketocholesterols; Oxidation-Reduction; Reactive Oxygen Species; U937 Cells | 1998 |
p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin.
Topics: Animals; Apoptosis; Carrier Proteins; Cell Cycle Proteins; Cycloheximide; DNA; DNA Damage; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; E2F Transcription Factors; E2F1 Transcription Factor; Etoposide; Humans; Mice; Retinoblastoma Protein; Retinoblastoma-Binding Protein 1; Transcription Factor DP1; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1999 |
Degradation of eukaryotic polypeptide chain initiation factor (eIF) 4G in response to induction of apoptosis in human lymphoma cell lines.
Topics: Amino Acid Chloromethyl Ketones; Antibodies; Apoptosis; Caspase Inhibitors; Caspases; Culture Media, Serum-Free; Cycloheximide; Etoposide; Eukaryotic Initiation Factor-4E; fas Receptor; Half-Life; Humans; Jurkat Cells; Lymphoma; Molecular Weight; Neoplasm Proteins; Oligopeptides; Peptide Initiation Factors; Poly(A)-Binding Proteins; Poly(ADP-ribose) Polymerases; Protein Synthesis Inhibitors; RNA-Binding Proteins; Sirolimus; Tumor Cells, Cultured | 1998 |
Nuclear foci of mammalian recombination proteins are located at single-stranded DNA regions formed after DNA damage.
Topics: Animals; Cell Cycle; Cell Line; Cell Nucleus; Chromatin; Cycloheximide; Dactinomycin; DNA Damage; DNA, Single-Stranded; Etoposide; Fibroblasts; Gamma Rays; Humans; Kinetics; Mammals; Meiosis; Mitomycin; Nuclear Proteins; Rats; Recombinant Proteins; Sensitivity and Specificity; Xeroderma Pigmentosum | 1999 |
Apoptotic human lymphocytes have diminished CD4 and CD8 receptor expression.
Topics: Apoptosis; CD3 Complex; CD4 Antigens; CD8 Antigens; Cycloheximide; Etoposide; Humans; Lymphocytes; Necrosis; Transglutaminases | 1999 |
Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction.
Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Caspase 8; Caspase 9; Caspases; Cycloheximide; Cysteine Proteinase Inhibitors; Daunorubicin; Doxorubicin; Enzyme Activation; Etoposide; Fas Ligand Protein; fas Receptor; HeLa Cells; Humans; Jurkat Cells; Membrane Glycoproteins; Mitomycin; Recombinant Fusion Proteins; T-Lymphocytes; Transfection; Tumor Cells, Cultured | 1999 |
Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Carcinogens; Caspase 2; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Adhesion; Cell Differentiation; Cycloheximide; Cytochrome c Group; Enzyme Precursors; Etoposide; Fas Ligand Protein; Humans; Membrane Glycoproteins; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-bcl-2; Tetradecanoylphorbol Acetate; U937 Cells; Vinblastine | 1999 |
Redistribution of cytochrome c precedes the caspase-dependent formation of ultracondensed mitochondria, with a reduced inner membrane potential, in apoptotic monocytes.
Topics: Actins; Amino Acid Chloromethyl Ketones; Apoptosis; Caspases; Cycloheximide; Cysteine Proteinase Inhibitors; Cytochrome c Group; Cytoskeleton; Etoposide; Flow Cytometry; Golgi Apparatus; Humans; Immunohistochemistry; Membrane Potentials; Mitochondria; Monocytes; Nucleic Acid Synthesis Inhibitors; Protein Synthesis Inhibitors; Tumor Cells, Cultured | 1999 |
Etoposide-induced apoptosis is not associated with the fas pathway in acute myeloblastic leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Cycloheximide; Etoposide; Fas Ligand Protein; fas Receptor; Humans; Leukemia, Myeloid, Acute; Membrane Glycoproteins; Tumor Cells, Cultured | 2000 |
Sensitisation of HL60 human leukaemic cells to cytotoxic drug-induced apoptosis by inhibition of PI3-kinase survival signals.
Topics: Androstadienes; Antineoplastic Agents; Apigenin; Apoptosis; bcl-Associated Death Protein; bcl-X Protein; Camptothecin; Carrier Proteins; Cell Survival; Chromones; Cycloheximide; Dactinomycin; Dimerization; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Flavonoids; Genes, bcl-2; HL-60 Cells; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Mitoxantrone; Morpholines; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Sirolimus; Wortmannin | 2000 |
Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c release.
Topics: Animals; Apoptosis; Aspartic Acid; BH3 Interacting Domain Death Agonist Protein; Carrier Proteins; Caspase 3; Caspases; Catalysis; Cell-Free System; Cycloheximide; Cytochrome c Group; Enzyme Inhibitors; Etoposide; Humans; Jurkat Cells; Mice; Mitochondria, Liver; Nucleic Acid Synthesis Inhibitors; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-bcl-2; Staurosporine; Tumor Cells, Cultured; Ultraviolet Rays | 2000 |
p27KIP1 is down-regulated by two different mechanisms in human lymphoid cells undergoing apoptosis.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; B-Lymphocytes; Caspase 8; Caspase 9; Caspase Inhibitors; Caspases; Cell Cycle Proteins; Cell Line, Transformed; Cyclin-Dependent Kinase Inhibitor p27; Cycloheximide; Down-Regulation; Etoposide; fas Receptor; Humans; Jurkat Cells; Microtubule-Associated Proteins; Nucleic Acid Synthesis Inhibitors; Protein Synthesis Inhibitors; Proteins; Signal Transduction; T-Lymphocytes; Tumor Suppressor Proteins | 2000 |
Cleavage of polypeptide chain initiation factor eIF4GI during apoptosis in lymphoma cells: characterisation of an internal fragment generated by caspase-3-mediated cleavage.
Topics: Apoptosis; Blotting, Western; Burkitt Lymphoma; Caspase 3; Caspases; Cell Cycle; Cycloheximide; DNA; Endopeptidases; Etoposide; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factor-4G; Humans; Nucleic Acid Synthesis Inhibitors; Peptide Chain Initiation, Translational; Peptide Fragments; Peptide Initiation Factors; Protein Biosynthesis; Protein Synthesis Inhibitors; Tumor Cells, Cultured | 2000 |
Heat-shock proteins inhibit induction of prostate cancer cell apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Blotting, Western; Cycloheximide; Etoposide; Glutathione; Glutathione Transferase; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; HSP72 Heat-Shock Proteins; Humans; Kinetics; Male; Maleates; Molecular Chaperones; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nucleic Acid Synthesis Inhibitors; Prostatic Neoplasms; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; Tumor Cells, Cultured | 2000 |
Behaviour of mouse primary spermatocyte nuclei after fusion to enucleated metaphase II oocytes.
Topics: Animals; Cell Division; Cell Fusion; Cell Nucleus; Cycloheximide; DNA Replication; Etoposide; Female; Karyotyping; Male; Metaphase; Mice; Mice, Inbred Strains; Oocytes; Sexual Maturation; Spermatocytes; Testis | 2000 |
Natural protection from apoptosis by surfactant protein A in type II pneumocytes.
Topics: Animals; Apoptosis; Carrier Proteins; Cell Separation; Cells, Cultured; Cycloheximide; Dexamethasone; Enzyme Inhibitors; Etoposide; Female; Flow Cytometry; Glucocorticoids; Glycoproteins; Humans; In Situ Nick-End Labeling; Nucleic Acid Synthesis Inhibitors; Phosphatidylinositol 3-Kinases; Protein Synthesis Inhibitors; Proteolipids; Pulmonary Alveoli; Pulmonary Surfactant-Associated Protein A; Pulmonary Surfactant-Associated Proteins; Pulmonary Surfactants; Rats; Signal Transduction; Staurosporine; Ultraviolet Rays | 2001 |
DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis.
Topics: Apoptosis; Cell Nucleus; Cell Survival; Cycloheximide; Dactinomycin; Deoxyribonuclease I; DNA; DNA Fragmentation; Etoposide; fas Receptor; Gene Targeting; Humans; Jurkat Cells; Kinetics; Nucleosomes; Paclitaxel; Transfection; Tumor Cells, Cultured | 2001 |
Cleavage of the Bloom's syndrome gene product during apoptosis by caspase-3 results in an impaired interaction with topoisomerase IIIalpha.
Topics: Adenosine Triphosphatases; Apoptosis; Bloom Syndrome; Caspase 3; Caspases; Cycloheximide; DNA Helicases; DNA Topoisomerases, Type I; Etoposide; HeLa Cells; HL-60 Cells; Humans; Models, Biological; Molecular Weight; Protein Binding; Protein Processing, Post-Translational; Protein Structure, Tertiary; RecQ Helicases; Tumor Necrosis Factor-alpha | 2001 |
MEKK1 is essential for DT40 cell apoptosis in response to microtubule disruption.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Southern; Blotting, Western; Cell Cycle; Cell Line; Chickens; Cycloheximide; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Etoposide; G2 Phase; Gene Library; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 1; Microtubules; Mitogen-Activated Protein Kinases; Mitosis; Nucleic Acid Synthesis Inhibitors; Phosphorylation; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Synthesis Inhibitors; Signal Transduction; Thymidine; Time Factors; Transfection; Vinblastine | 2001 |
Phorbol 12-myristate 13-acetate inhibits death receptor-mediated apoptosis in Jurkat cells by disrupting recruitment of Fas-associated polypeptide with death domain.
Topics: Adaptor Proteins, Signal Transducing; Antigens, CD; Apoptosis; Apoptosis Regulatory Proteins; Binding Sites; Camptothecin; Carrier Proteins; Cell Line; Cycloheximide; Etoposide; fas Receptor; Fas-Associated Death Domain Protein; Gamma Rays; HSP90 Heat-Shock Proteins; Humans; Jurkat Cells; Kinetics; Membrane Glycoproteins; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Tetradecanoylphorbol Acetate; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |
Expression level of c-FLIP versus Fas determines susceptibility to Fas ligand-induced cell death in murine thymoma EL-4 cells.
Topics: Animals; Apoptosis; Camptothecin; Carrier Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase Inhibitors; Cell Membrane; Cycloheximide; Down-Regulation; Doxorubicin; Etoposide; Fas Ligand Protein; fas Receptor; Gene Expression; Intracellular Signaling Peptides and Proteins; Membrane Glycoproteins; Mice; Mitomycin; Protein Synthesis Inhibitors; Thymoma; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Up-Regulation | 2002 |
The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c.
Topics: Androstadienes; Animals; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Cell Line; Cell Survival; Cells, Cultured; Chloride Channels; Cycloheximide; Cytochrome c Group; Cytosol; Diuretics; DNA Damage; Enzyme Inhibitors; Etoposide; Fibroblasts; Furosemide; Mice; Mitochondria; Nucleic Acid Synthesis Inhibitors; Phosphorylation; Protein Synthesis Inhibitors; Protein Transport; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Time Factors; Transfection; Tumor Suppressor Protein p53; Ubiquinone; Up-Regulation; Wortmannin | 2002 |
Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Proteins; Cisplatin; Combined Modality Therapy; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cycloheximide; DNA-Binding Proteins; Doxorubicin; Drug Synergism; E2F Transcription Factors; E2F1 Transcription Factor; Enzyme Inhibitors; Etoposide; Fluorouracil; Genetic Therapy; Genetic Vectors; Humans; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Proliferating Cell Nuclear Antigen; Purines; Roscovitine; Topoisomerase II Inhibitors; Transcription Factors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |
Carbon monoxide protects pancreatic beta-cells from apoptosis and improves islet function/survival after transplantation.
Topics: Animals; Apoptosis; Carbon Monoxide; Cell Survival; Cycloheximide; Cysteine Proteinase Inhibitors; DNA Fragmentation; Enzyme Activation; Etoposide; Graft Survival; Guanylate Cyclase; Insulinoma; Islets of Langerhans; Islets of Langerhans Transplantation; Kinetics; Male; Mice; Mice, Inbred C57BL; Oligopeptides; Pancreatic Neoplasms; Recombinant Proteins; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |
Hsp105alpha enhances stress-induced apoptosis but not necrosis in mouse embryonal f9 cells.
Topics: Animals; Apoptosis; Caspase 3; Caspase 9; Caspases; Cell Line; Cell Survival; Cycloheximide; Cytochrome c Group; DNA Fragmentation; Embryo, Mammalian; Enzyme Precursors; Etoposide; Hot Temperature; HSP110 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; JNK Mitogen-Activated Protein Kinases; Mice; Mitogen-Activated Protein Kinases; Necrosis; Nucleic Acid Synthesis Inhibitors; p38 Mitogen-Activated Protein Kinases; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Synthesis Inhibitors; Proteins | 2002 |
Different effects of p58PITSLRE on the apoptosis induced by etoposide, cycloheximide and serum-withdrawal in human hepatocarcinoma cells.
Topics: Apoptosis; Blood Volume; Cell Death; Culture Media, Serum-Free; Cyclin-Dependent Kinases; Cycloheximide; Etoposide; Female; Humans; In Situ Nick-End Labeling; Liver; Liver Neoplasms; Luminescent Measurements; Protein Kinases; Protein Serine-Threonine Kinases; Tumor Cells, Cultured | 2002 |
Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway.
Topics: Androstadienes; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cycloheximide; DNA; DNA Damage; DNA-Binding Proteins; Enzyme Inhibitors; Etoposide; Fibroblasts; Gamma Rays; Genes, p53; Genes, Reporter; Humans; Interferon Regulatory Factor-1; Melanoma; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphoproteins; Phosphorylation; Poly I-C; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Synthesis Inhibitors; Recombinant Fusion Proteins; RNA, Messenger; Signal Transduction; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Wortmannin | 2002 |
Inositol 1,3,4-trisphosphate 5/6-kinase inhibits tumor necrosis factor-induced apoptosis.
Topics: Antigens, CD; Apoptosis; Blotting, Northern; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Line; Cycloheximide; DNA; Dose-Response Relationship, Drug; Etoposide; HeLa Cells; Humans; Phosphotransferases (Alcohol Group Acceptor); Poly(ADP-ribose) Polymerases; Protein Binding; Protein Structure, Tertiary; Protein Synthesis Inhibitors; Protein Transport; Proteins; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Time Factors; TNF Receptor-Associated Factor 1; Transcription, Genetic; Transfection; Tumor Necrosis Factor-alpha | 2003 |
Dual role of NF-kappaB in apoptosis of THP-1 cells during treatment with etoposide and lipopolysaccharide.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Caspase Inhibitors; Caspases; Cycloheximide; Dactinomycin; Drug Therapy, Combination; Enzyme Inhibitors; Etoposide; Humans; Inhibitor of Apoptosis Proteins; Leukemia; Lipopolysaccharides; NF-kappa B; Protein Synthesis Inhibitors; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tosyllysine Chloromethyl Ketone; Tumor Cells, Cultured; X-Linked Inhibitor of Apoptosis Protein | 2004 |
Comparison of bulk enucleation methods for porcine oocytes.
Topics: Animals; Cell Fractionation; Cell Nucleus; Cloning, Organism; Cycloheximide; Etoposide; Maturation-Promoting Factor; Micromanipulation; Nucleic Acid Synthesis Inhibitors; Oocytes; Protein Kinases; Protein Synthesis Inhibitors; Swine; Time Factors | 2004 |
Increased calcium influx and ribosomal content correlate with resistance to endoplasmic reticulum stress-induced cell death in mutant leukemia cell lines.
Topics: Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Area Under Curve; Calcium; Cell Death; Cell Line, Tumor; Cycloheximide; Dithiothreitol; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Econazole; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Etoposide; Fas Ligand Protein; Flow Cytometry; HL-60 Cells; Humans; Leukemia; Membrane Glycoproteins; Oligonucleotide Array Sequence Analysis; Phenotype; Ribosomes; Thapsigargin; Time Factors; Tunicamycin | 2004 |
The DNA damaging agent VP16 induces the expression of a subset of ligands from the EGF system in bladder cancer cells, whereas none of the four EGF receptors are induced.
Topics: Amphiregulin; Antineoplastic Agents, Phytogenic; Betacellulin; Cell Line, Tumor; Cell Membrane; Cycloheximide; Dose-Response Relationship, Drug; EGF Family of Proteins; Epidermal Growth Factor; Epiregulin; ErbB Receptors; Etoposide; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Intercellular Signaling Peptides and Proteins; Ligands; Protein Synthesis Inhibitors; RNA, Messenger; Transforming Growth Factor alpha; Urinary Bladder Neoplasms | 2004 |
Dual effects of cycloheximide on U937 apoptosis induced by its combination with VP-16.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Cycloheximide; Dose-Response Relationship, Drug; Etoposide; Humans; U937 Cells | 2004 |
A death receptor-associated anti-apoptotic protein, BRE, inhibits mitochondrial apoptotic pathway.
Topics: Apoptosis; Base Sequence; Cell Nucleus; Cycloheximide; Cytosol; Etoposide; fas Receptor; Gene Expression; HeLa Cells; Humans; Jurkat Cells; Mitochondria; Nerve Tissue Proteins; Receptors, Tumor Necrosis Factor, Type I; Recombinant Proteins; RNA, Small Interfering; Transfection; Tumor Necrosis Factor-alpha | 2004 |
Resistance to Fas-mediated apoptosis is restored by cycloheximide through the downregulation of cellular FLIPL in NK/T-cell lymphoma.
Topics: Antibodies, Monoclonal; Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; Calcium-Calmodulin-Dependent Protein Kinases; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspases; Cell Proliferation; Cell Survival; Cycloheximide; Death-Associated Protein Kinases; Decitabine; Down-Regulation; Enzyme Activation; Etoposide; fas Receptor; Humans; Intracellular Signaling Peptides and Proteins; Jurkat Cells; Killer Cells, Natural; Lymphoma, T-Cell, Peripheral; Protein Synthesis Inhibitors | 2005 |
Inhibition of apoptosis by Nur77 through NF-kappaB activity modulation.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Camptothecin; Cell Line; Cycloheximide; DNA Damage; DNA-Binding Proteins; Endoplasmic Reticulum; Etoposide; Fas Ligand Protein; Fibroblasts; Gene Expression Regulation; Humans; Inhibitor of Apoptosis Proteins; Membrane Glycoproteins; NF-kappa B; Nuclear Receptor Subfamily 4, Group A, Member 1; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Thapsigargin; Transcription Factors; Transfection; Tumor Necrosis Factors | 2006 |
Cleavage of claspin by caspase-7 during apoptosis inhibits the Chk1 pathway.
Topics: Adaptor Proteins, Signal Transducing; Amino Acid Motifs; Amino Acid Sequence; Animals; Apoptosis; Aspartic Acid; Binding Sites; Caspase 7; Caspases; Cell Cycle; Cell Line; Cell Nucleus; Cell-Free System; Checkpoint Kinase 1; Cycloheximide; Cytosol; DNA; DNA Replication; Dose-Response Relationship, Drug; Drosophila; Etoposide; HeLa Cells; Humans; Immunoprecipitation; Jurkat Cells; Mice; Models, Biological; Molecular Sequence Data; Oligonucleotides; Phosphorylation; Protein Binding; Protein Kinases; Protein Structure, Tertiary; Protein Synthesis Inhibitors; Recombinant Proteins; Sequence Homology, Amino Acid; Signal Transduction; Time Factors; Xenopus; Xenopus Proteins | 2005 |
The extracellular release of HMGB1 during apoptotic cell death.
Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Cell Line; Cycloheximide; Cysteine Proteinase Inhibitors; Enzyme Inhibitors; Etoposide; HMGB1 Protein; Humans; Hydroxamic Acids; Protein Synthesis Inhibitors; Staurosporine; Tumor Necrosis Factor-alpha | 2006 |
Cycloheximide protects HepG2 cells from serum withdrawal-induced apoptosis by decreasing p53 and phosphorylated p53 levels.
Topics: Actins; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Cycloheximide; Dactinomycin; DNA Fragmentation; Doxorubicin; Etoposide; Flow Cytometry; Humans; Phosphorylation; Protein Synthesis Inhibitors; Reactive Oxygen Species; RNA, Small Interfering; Transfection; Trypan Blue; Tumor Suppressor Protein p53 | 2006 |
Changes in gap junction organization and decreased coupling during induced apoptosis in lens epithelial and NIH-3T3 cells.
Topics: Animals; Apoptosis; Caspases; Cattle; Cells, Cultured; Connexin 43; Cycloheximide; Epithelial Cells; Etoposide; Gap Junctions; Lens, Crystalline; Mice; NIH 3T3 Cells; Phosphorylation; Puromycin; Staurosporine | 2007 |
Malignant mesothelioma cells are rapidly sensitized to TRAIL-induced apoptosis by low-dose anisomycin via Bim.
Topics: Anisomycin; Annexin A5; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Combined Modality Therapy; Cycloheximide; Drug Synergism; Electrophoresis, Gel, Two-Dimensional; Etoposide; Humans; Immunoblotting; JNK Mitogen-Activated Protein Kinases; Ligands; Membrane Proteins; Mesothelioma; Phosphorylation; Protein Synthesis Inhibitors; Proto-Oncogene Proteins; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured | 2007 |
alphaB-crystallin is mutant B-RAF regulated and contributes to cyclin D1 turnover in melanocytic cells.
Topics: alpha-Crystallin B Chain; Bleomycin; Butadienes; Cells, Cultured; Cyclin D1; Cycloheximide; DNA Damage; Etoposide; Humans; Leupeptins; Melanocytes; Melanoma; Mutant Proteins; Mutation; Nitriles; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Structure-Activity Relationship; Tetracycline | 2010 |
Apoptosis induced clustering of IP(3)R1 in nuclei of non-differentiated PC12 cells.
Topics: Active Transport, Cell Nucleus; Animals; Apoptosis; bcl-2-Associated X Protein; Boron Compounds; Calcium; Camptothecin; Caspase 3; Cell Differentiation; Cell Nucleus; Cycloheximide; Dactinomycin; Dexamethasone; Etoposide; Inositol 1,4,5-Trisphosphate Receptors; PC12 Cells; Permeability; Rats; RNA, Messenger; Time Factors; Up-Regulation | 2011 |
Attenuation of nonsense-mediated mRNA decay facilitates the response to chemotherapeutics.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Codon, Nonsense; Cycloheximide; Doxorubicin; Etoposide; HEK293 Cells; HeLa Cells; Humans; Jurkat Cells; MCF-7 Cells; Nonsense Mediated mRNA Decay; Protein Synthesis Inhibitors; RNA Helicases; RNA, Messenger; Trans-Activators | 2015 |